Table 3.
Complications of surgery in late presenters of TOF and methods to minimize those
| Complications | Causes | How to minimise |
|---|---|---|
| Arrhythmias |
Myocardial fibrosis Altered conduction pathways |
Careful selection of anesthetic agents. Monitoring to maintain hemodynamic stability Minimize arrhythmogenic triggers Avoid excessive β adrenergic support, Pacemaker |
| Bleeding |
Coagulopathy due to chronic hypoxia Thrombocytopenia |
Folic acid supplements Adequate blood products Hemostatic drugs Preoperative/intraoperative phlebotomy in operating room Minimally invasive approaches where feasible Avoid excessive endotracheal suction, proper hemostasis |
| Left heart return |
MAPCAs Other collateral blood flow |
Moderate hypothermia with cooling to 25–26 °C |
| Transient/persistent myocardial dysfunction |
Effects of cardiopulmonary bypass Residual defects Myocardial ischemia Pulmonary regurgitation Tricuspid regurgitation |
Minimizing the duration of bypass Avoid injury to coronary arteries Meticulous closure of ventricular septal defect (VSD) Attempt a purely trans right atrial approach or Trans-RV with a minimum ventriculotomy Avoid excessive infundibular resection Avoid liberal use of TAP Preservation of pulmonary valve function (reconstruction/replacement) Preservation tricuspid/pulmonary valve function Prefer milrinone as inotropic agent Need higher filling pressures due to RV diastolic dysfunction Optimize mode of ventilation, duration of ventilation and the degree of positive end expiratory pressure (PEEP) |
| Pulmonary artery complications |
Narrowing Kinking Thrombosis |
|
| Infective endocarditis | Prosthetic materials |
MAPCA; major aortopulmonary collateral arteries, RV; right ventricle, TAP; transannular patch, VSD; ventricular septal defect, PEEP; positive end expiratory pressure